New Anorectic Drugs in the Pipeline
WebcastFaculty
OVERVIEW
New Anorectic Drugs in the Pipeline is organized by Obesity Medicine Association (OMA) and will be held during Apr 10, 2015 - Apr 05, 2018. This CME Conference has been approved for a maximum of 0.75 AMA PRA Category 1 Credits.
Conference Description :
Dr. Greenway will familiarize learners with the current anorectic medications in late-stage obesity trials. Learn about the drugs and drug combinations currently in obesity research trials and become aware of future medications and therapeutic targets for obesity drugs.
Conference Objectives are:
• Discuss prescribing off-label combination medications, such as lorcaserin-phentermine, pramlintide-phentermine, bupropion-zonisamide phase II, SGLT-2 inhibitor combinations.
• Review drugs that are not yet available, but in development.
Additional details will be posted as soon as they are available.
Conference Description :
Dr. Greenway will familiarize learners with the current anorectic medications in late-stage obesity trials. Learn about the drugs and drug combinations currently in obesity research trials and become aware of future medications and therapeutic targets for obesity drugs.
Conference Objectives are:
• Discuss prescribing off-label combination medications, such as lorcaserin-phentermine, pramlintide-phentermine, bupropion-zonisamide phase II, SGLT-2 inhibitor combinations.
• Review drugs that are not yet available, but in development.
Additional details will be posted as soon as they are available.
SPECIALITIES
Pharmacy and Medicine
Quick Links